AC
EDIT icon

AXQ Capital’s Editas Medicine EDIT Stock Holding History

AXQ Capital’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-47,083
Closed -$104K – 647
2025
Q2 		$104K Buy
+47,083
New +$77K 0.03% 516
2023
Q3 		– Sell
-10,072
Closed -$82.9K – 508
2023
Q2 		$82.9K Buy
+10,072
New +$87.7K 0.1% 249
2023
Q1 		– Sell
-20,801
Closed -$185K – 516
2022
Q4 		$185K Buy
+20,801
New +$228K 0.13% 275

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AXQ Capital's EDIT Position: Q3 2025 in Review

AXQ Capital sold out of Editas Medicine (EDIT) in Q3 2025, closing a stake of 47,083 shares — an estimated $104K sold.

AXQ Capital first reported a position in EDIT in Q4 2022 and held it in 3 quarters. The position peaked at $185K in Q4 2022. 193 funds tracked by Wall St. Rank hold EDIT as of Q3 2025.

  • AXQ Capital reported no remaining Editas Medicine position as of Q3 2025 after selling out during the quarter.
  • AXQ Capital sold 47,083 Editas Medicine shares in Q3 2025, an estimated $104K.
  • AXQ Capital first reported a position in Editas Medicine in Q4 2022 and held it in 3 quarters.
  • AXQ Capital's Editas Medicine position peaked at $185K in Q4 2022.
  • 193 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2025.

Based on AXQ Capital's 13F filing for Q3 2025, filed 10 Nov 2025.